News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Fiona BARRY
- Last updated on
Rolland Carlson has been appointed President and CEO of WaferGen Bio-systems. The Californian company offers tools to clinical researchers, including a high-throughput genetic analysis platform for profiling biomarkers via microRNA and mRNA.
Carlson will take over from Ivan Trifunovich, who has served as President and CEO of WaferGen since March 2012.
"With the significant progress we have achieved with single cell analysis, and a commercial launch on the near-term horizon, now is the right time for this transition to occur," said the outgoing Chief Executive.
"Moreover, Rollie's extensive commercial and operational experience in the life science, molecular diagnostics, and pharmaceuticals industries makes him the ideal fit to lead WaferGen at this critical juncture in the Company's lifecycle.”
Carlson previously led Asuragen, Inc., a private molecular diagnostics company. During his time as CEO, the company raised $55m in venture and grant funding and saw sales over $27m in 2013.